Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Blankenstein, Thomas Prof. Dr. (16) Daniel, Peter Prof. Dr. (1) Jarosch, Ernst Dr. (5) Kammertöns, Thomas Dr. (5) Leisegang, Matthias Prof. Dr. rer. nat. (1) Pezzutto, Antonio Prof. Dr. (2) Quensel, Christina Dr. (1) Selbach, Matthias Prof. Dr. (1) Sommer, Thomas Prof. Dr. (11) Willimsky, Gerald Dr. (1) (-) Kopp, Joachim Dr. (1) (-) Nguyen, Tam Hoai Dr. (1) (-) Uckert, Wolfgang Prof. Dr. (4) Epigenetische Regulation und Chromatinstruktur (9) (-) Intrazelluläre Proteolyse (1) Molekulare Herz- Kreislaufforschung (1) (-) Molekulare Immunologie und Gentherapie (6) Pancreatic Organoid Research and Disease Modeling (1) Proteom Dynamik (1) RNA Biologie und Posttranscriptionale Regulation (1) Systembiologie von Gen-regulatorischen Elementen (3) Translationale Onkologie solider Tumore (1) Zelluläre Neurowissenschaften (1) Zellzustände und ihre Funktionsweisen (1) 2002 (2) 2003 (4) (-) 2004 (3) 2005 (5) 2006 (1) 2007 (2) 2008 (1) 2010 (2) (-) 2011 (3) 2013 (1) (-) 2014 (1) 2015 (3) 2016 (2) 2017 (1) 2018 (2) 7 Ergebnisse: Active Filter: Kopp, Joachim Dr.Nguyen, Tam Hoai Dr.Uckert, Wolfgang Prof. Dr.Intrazelluläre ProteolyseMolekulare Immunologie und Gentherapie 200420112014 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Januar 2004 / Gene Ther Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization J. Westermann T. Nguyen-Hoai A. Mollweide G. Richter O. Schmetzer H.J. Kim T. Blankenstein B. Doerken A. Pezzutto 01. Juli 2004 / Eur J Immunol Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors M. Gladow W. Uckert T. Blankenstein 01. Januar 2004 / Mol Cell Vpu-mediated degradation of CD4 reconstituted in yeast reveals mechanistic differences to cellular ER-associated protein degradation B. Meusser T. Sommer 28. Juli 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein 15. Januar 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens 01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto 01. September 2014 / Eur J Immunol Misinitiation of intrathymic MART-1 transcription and biased TCR usage explain the high frequency of MART-1-specific T cells S. Pinto D. Sommermeyer C. Michel S. Wilde D. Schendel W. Uckert T. Blankenstein B. Kyewski
01. Januar 2004 / Gene Ther Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization J. Westermann T. Nguyen-Hoai A. Mollweide G. Richter O. Schmetzer H.J. Kim T. Blankenstein B. Doerken A. Pezzutto
01. Juli 2004 / Eur J Immunol Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors M. Gladow W. Uckert T. Blankenstein
01. Januar 2004 / Mol Cell Vpu-mediated degradation of CD4 reconstituted in yeast reveals mechanistic differences to cellular ER-associated protein degradation B. Meusser T. Sommer
28. Juli 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein
15. Januar 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens
01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto
01. September 2014 / Eur J Immunol Misinitiation of intrathymic MART-1 transcription and biased TCR usage explain the high frequency of MART-1-specific T cells S. Pinto D. Sommermeyer C. Michel S. Wilde D. Schendel W. Uckert T. Blankenstein B. Kyewski